Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Novateor Research Laboratories's Cyclically Adjusted PS Ratio or its related term are showing as below:
BOM:542771'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 14.25 Med: 15 Max: 15.03
Current: 15.03
During the past 10 years, Novateor Research Laboratories's highest Cyclically Adjusted PS Ratio was 15.03. The lowest was 14.25. And the median was 15.00.
BOM:542771's Cyclically Adjusted PS Ratio is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.77
vs BOM:542771: 15.03
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Novateor Research Laboratories's adjusted revenue per share data of for the fiscal year that ended in Mar26 was ₹6.430. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹2.19 for the trailing ten years ended in Mar26.
Shiller PE for Stocks: The True Measure of Stock Valuation
Novateor Research Laboratories (BOM:542771) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Novateor Research Laboratories Cyclically Adjusted PS Ratio Related Terms
Novateor Research Laboratories Cyclically Adjusted PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novateor Research Laboratories Cyclically Adjusted PS Ratio Chart
BOM:542771 vs PG, CL, KVUE: Cyclically Adjusted PS Ratio Comparison
For the Household & Personal Products subindustry, Novateor Research Laboratories's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novateor Research Laboratories Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Novateor Research Laboratories's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Novateor Research Laboratories's Cyclically Adjusted PS Ratio falls into.
Novateor Research Laboratories Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 14.61 mean?
Novateor Research Laboratories (BOM:542771) has a Cyclically Adjusted PS Ratio of 14.61 as of Sep. 01, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novateor Research Laboratories and its competitors. This is near median its historical median of 15.00. Over the past decade, Novateor Research Laboratories' Cyclically Adjusted PS Ratio has ranged from 14.25 to 15.03.
Is Novateor Research Laboratories' Cyclically Adjusted PS Ratio too high?
Novateor Research Laboratories' current Cyclically Adjusted PS Ratio of 14.61 is near median its 10-year median of 15.00. Over the past 10 years, this metric has ranged from a low of 14.25 to a high of 15.03. The Consumer Packaged Goods industry median Cyclically Adjusted PS Ratio is 0.77. Novateor Research Laboratories' value of 14.61 is 1797.4% above this industry median. Overall, Novateor Research Laboratories has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Novateor Research Laboratories' Cyclically Adjusted PS Ratio compare to PG and CL?
Novateor Research Laboratories' Cyclically Adjusted PS Ratio of 14.61 can be compared against companies in the Consumer Packaged Goods industry. The industry median Cyclically Adjusted PS Ratio is 0.77. Novateor Research Laboratories' value of 14.61 is 1797.4% above this benchmark. Historically, Novateor Research Laboratories' own Cyclically Adjusted PS Ratio has ranged from 14.25 to 15.03 over the past decade. While the company's 10-year median is 15.00 vs. the industry median of 0.77, Novateor Research Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Consumer Packaged Goods company?
The median Cyclically Adjusted PS Ratio among Consumer Packaged Goods companies is 0.77, based on 1,444 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novateor Research Laboratories's current Cyclically Adjusted PS Ratio of 14.61 is 1797.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Novateor Research Laboratories and its competitors. For the Consumer Packaged Goods industry, the median Cyclically Adjusted PS Ratio is 0.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novateor Research Laboratories's current Cyclically Adjusted PS Ratio is 14.61, which is near median its own 10-year median of 15.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novateor Research Laboratories stock overvalued right now?
Novateor Research Laboratories (BOM:542771) has a current Cyclically Adjusted PS Ratio of 14.61. The stock's GF Value™ is ₹83.64, compared to a current price of ₹32.00 — trading 61.7% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 14.61, which is near median its 10-year median of 15.00 and 1797.4% above the Consumer Packaged Goods industry median of 0.77. Novateor Research Laboratories' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Novateor Research Laboratories (BOM:542771), the current Cyclically Adjusted PS Ratio is 14.61 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novateor Research Laboratories (BOM:542771) Overvalued in 2026?
Based on GuruFocus' analysis, Novateor Research Laboratories stock appears to be undervalued.
The current stock price of ₹32.00 is trading 61.7% below its estimated GF Value™ of ₹83.64.
Key valuation signals for BOM:542771:
Cyclically Adjusted PS Ratio: 14.61 (near median its 10-year median of 15.00)
GF Value™: ₹83.64 vs. price of ₹32.00 (61.7% below fair value)
Industry Position: 1797.4% above the Consumer Packaged Goods median
No single metric tells the full story. See the BOM:542771 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novateor Research Laboratories Ltd is a company engaged in the development of novel personal care products that are intended to provide safe, easy, and innovative approaches to the existing traditional personal care solutions. The company's teeth-whitening products are sold under the brand name SmiloShine. The company manufactures three different variants of teeth whitening strips, teeth whitening toothpaste and brush, kids's toothpaste and tongue cleaner, and teeth whitening gel.
59GF Score
Get the complete analysis for BOM:542771
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542771 has been successfully added to your 
